Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/9550
Full metadata record
DC FieldValueLanguage
dc.contributor.authorApostolopoulos, V.en
dc.contributor.authorThalhammer, T.en
dc.contributor.authorTzakos, A. G.en
dc.contributor.authorStojanovska, L.en
dc.date.accessioned2015-11-24T16:49:57Z-
dc.date.available2015-11-24T16:49:57Z-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/9550-
dc.rightsDefault Licence-
dc.titleTargeting Antigens to Dendritic Cell Receptors for Vaccine Developmenten
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primaryhttp://dx.doi.org/10.1155/2013/869718-
heal.identifier.secondaryhttp://www.hindawi.com/journals/jdd/2013/869718/-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείαςel
heal.publicationDate2013-
heal.abstractDendritic cells (DCs) are highly specialized antigen presenting cells of the immune system which play a key role in regulating immune responses. Depending on the method of antigen delivery, DCs stimulate immune responses or induce tolerance. As a consequence of the dual function of DCs, DCs are studied in the context of immunotherapy for both cancer and autoimmune diseases. In vaccine development, a major aim is to induce strong, specific T-cell responses. This is achieved by targeting antigen to cell surface molecules on DCs that efficiently channel the antigen into endocytic compartments for loading onto MHC molecules and stimulation of T-cell responses. The most attractive cell surface receptors, expressed on DCs used as targets for antigen delivery for cancer and other diseases, are discussed.en
heal.publisherHindawi Publishing Corporationen
heal.journalNameJ Drug Deliven
heal.journalTypepeer reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ

Files in This Item:
File Description SizeFormat 
Tzakos-2013-Targeting antigens to.pdf1.63 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons